We are live on ! Find out more
KP

Kiltearn Partners Portfolio holdings

AUM $372M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
+18.16%
3 Year Est. Return
+34.48%
5 Year Est. Return
+43.43%
10 Year Est. Return
+168.94%
AUM
$736M
AUM Growth
-$89.2M
Cap. Flow
-$144M
Cap. Flow %
-19.59%
Top 10 Hldgs %
56.88%
Holding
35
New
2
Increased
3
Reduced
28
Closed
2

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$30.4M
2
PII icon
Polaris
PII
+$7.5M
3
GILD icon
Gilead Sciences
GILD
+$5.54M
4
SOLV icon
Solventum
SOLV
+$2.45M
5
WH icon
Wyndham Hotels & Resorts
WH
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 20.3%
2 Consumer Discretionary 14.58%
3 Financials 13.19%
4 Industrials 12.49%
5 Communication Services 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$650B
$9.42M 1.28%
80,383
-36,000
-31% -$4.16M
WBA
27
DELISTED
Walgreens Boots Alliance
WBA
$8.04M 1.09%
897,100
-162,400
-15% -$1.67M
G icon
28
Genpact
G
$6.22B
$7.66M 1.04%
195,250
-11,650
-6% -$421K
MU icon
29
Micron Technology
MU
$835B
$6.99M 0.95%
67,376
-26,630
-28% -$2.78M
GILD icon
30
Gilead Sciences
GILD
$165B
$6.09M 0.83%
+72,600
New +$5.54M
KT icon
31
KT
KT
$8.73B
$5.12M 0.7%
332,710
-716,800
-68% -$10.3M
WH icon
32
Wyndham Hotels & Resorts
WH
$5.61B
$4.88M 0.66%
62,400
+15,458
+33% +$1.17M
SOLV icon
33
Solventum
SOLV
$15.3B
$2.84M 0.39%
+40,700
New +$2.45M
DOW icon
34
Dow Inc
DOW
$22B
-231,337
Closed -$12.3M
GOOGL icon
35
Alphabet (Google) Class A
GOOGL
$4.12T
-64,600
Closed -$11.8M

Similar funds

Kiltearn Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Kiltearn Partners held 35 positions worth $736M, down 11% from $825M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Kiltearn Partners withdrew a net $144M in Q3 2024, closing 2 positions and reducing 28 holdings. Its most notable exit was Dow Inc, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Kiltearn Partners opened a new position in Gilead Sciences worth $6.09M.

  • Kiltearn Partners's largest Q3 2024 buy was Gilead Sciences: 72,600 shares worth $6.09M.
  • Kiltearn Partners added most to Dollar General in Q3 2024, an estimated $30.4M increase.
  • Kiltearn Partners's biggest Q3 2024 reduction was Check Point Software Technologies, cutting an estimated $25.6M.
  • Kiltearn Partners fully exited Dow Inc in Q3 2024, selling an estimated $12.3M.
  • Kiltearn Partners's ten largest holdings make up 57% of its $736M portfolio in Q3 2024.
  • Kiltearn Partners opened 2 new positions and closed 2 in Q3 2024.
  • Kiltearn Partners's portfolio value fell 11% quarter-over-quarter to $736M.

Based on Kiltearn Partners's 13F filing for Q3 2024, filed 13 Nov 2024.